# Aligos Therapeutics, Inc.: Form 8-K, filed Aug 5, 2021

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2021-08-05
- Accepted by EDGAR: Aug 5, 2021, 16:06 ET
- Period: 2021-08-05
- Accession: 0001171843-21-005574
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000117184321005574/f8k_080521.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000117184321005574/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000117184321005574/f8k_080521.htm

Filed Aug 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001171843-21-005574. Last ingested by Listed: Nov 14, 2026, 12:59 ET. No prices; not investment advice.
